A
2.65
0.40 (17.52%)
| 前收盘价格 | 2.26 |
| 收盘价格 | 2.28 |
| 成交量 | 15,255,172 |
| 平均成交量 (3个月) | 10,618,512 |
| 市值 | 331,108,832 |
| 价格/销量 (P/S) | 1.93 |
| 股市价格/股市净资产 (P/B) | 39.99 |
| 52周波幅 | |
| 利润日期 | 12 Nov 2025 |
| 营业毛利率 | -38.58% |
| 营业利益率 (TTM) | -39.35% |
| 稀释每股收益 (EPS TTM) | -0.400 |
| 季度盈利增长率 (YOY) | 378.90% |
| 总债务/股东权益 (D/E MRQ) | 48.89% |
| 流动比率 (MRQ) | 0.830 |
| 营业现金流 (OCF TTM) | 1.78 M |
| 杠杆自由现金流 (LFCF TTM) | 5.68 M |
| 资产报酬率 (ROA TTM) | -10.26% |
| 股东权益报酬率 (ROE TTM) | -37.82% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Software - Application (US) | 混合的 | 混合的 |
| Software - Application (全球的) | 混合的 | 混合的 | |
| 股票 | ALT5 Sigma Corporation | - | - |
AIStockmoo 评分
0.9
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.88 |
|
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment. |
|
| 部门 | Technology |
| 行业 | Software - Application |
| 投资方式 | Small Value |
| 内部持股比例 | 13.14% |
| 机构持股比例 | 7.89% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合